Providers/Grant Support
This activity is supported by educational grants from Incyte and Novartis Pharmaceuticals Corporation.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 CreditsTM
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Program Overview
Join our experts, Dr. Jennifer Hsiao and Dr. Iltefat Hamzavi, for this short Seminar-in-Depth, delivered during the 2025 Fall Clinical Dermatology Conference®. This session is intended to improve clinicians’ ability to identify patients with HS who would benefit from systemic therapy and to make evidence-based treatment choices that align with patients’ needs.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Explain the burden of hidradenitis suppurativa (HS) as it relates to delayed diagnosis
- Identify patients with moderate to severe HS who would be suitable candidates for new and emerging targeted therapies
- Describe the latest clinical efficacy and safety data for new and emerging targeted therapies for HS
- Select targeted therapies for patients with HS based on factors like clinical presentation and patient preference
Faculty
Iltefat Hamzavi, MD
Dermatologist
Hamzavi Dermatology
Co-Director of the Investigator-Initiated Research Unit
Henry Ford Medical Center, MI
Jennifer Hsiao, MD
Dermatologist and Clinical Associate Professor
Keck School of Medicine
University of Southern California
Los Angeles, CA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflict of Interest
Faculty
Iltefat Hamzavi, MD
No relevant financial relationships with any Ineligible Company in the past 24 months.
Jennifer Hsiao, MD
Consultant: AbbVie, Aclaris, Boehringer Ingelheim, Incyte, Moonlake, Navigator Medicines, Novartis, Pfizer, Sanofi, Regeneron, UCB
Speakers’ Bureau or Honoraria: AbbVie, Galderma, Novartis, Sanofi, Regeneron, UCB
Royalty: Elsevier (co-editor of textbook: A Comprehensive Guide to Hidradenitis Suppurative)
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
The Institute requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]